8/21/2024, Tampa, FL – Verséa Health, Inc. (“Verséa”), a Florida-based transformative healthcare company specializing in the commercialization of innovative diagnostics, therapeutics, and health services, has officially launched Party Safe™ Fentanyl ID Test.
Manufactured by a leading US supplier to law enforcement and healthcare providers, Party Safe™ Fentanyl ID Test is a dependable over-the-counter product, featuring 5 test strips, an easy-to-use format, and a straightforward instruction sheet.
Designed with simplicity and convenience in mind, the test enables users to detect the presence of fentanyl, a potent and deadly synthetic opioid, in various substances within minutes.
“With the fentanyl crisis impacting communities across our nation, Verséa Health recognized the urgent need to equip people with accessible and reliable fentanyl detection tool,” said James M. Olin, Chief Commercial Officer of Verséa Health, Inc. “By launching the Party Safe™ Fentanyl ID Test, we aim to empower individuals from all walks of life, particularly those navigating social scenes where substance use may occur, to make informed decisions and promote a safer environment for all.”
As fentanyl continues to pose a significant threat to public health, the Party Safe™ Fentanyl ID Test offers a valuable resource for individuals, community organizations, and healthcare professionals to help mitigate risks associated with fentanyl exposure.
The Party Safe™ Fentanyl ID Test is available for purchase through retail locations across the United States and online at Amazon.com.
To inquire about distributorship opportunities or to learn more about the Party Safe™ Fentanyl ID Test, please reach out to Verséa Health, Inc. at diagnostics@versea.com or 1-800-397-0670.
About Verséa Health, Inc.
Verséa Health, Inc. (“Verséa”) headquartered in Tampa, FL, is a U.S. based transformative health care company on a mission to deliver their “3P’s Model”: Proactive Health, Preventative Health, and Precision Medicine. Verséa Health operates across three strategic business units: Diagnostics (Professional & Consumer), Ophthalmics, and Discovery. To learn more, visit: www.versea.com
Disclaimer: Party Safe™ is not for in vitro diagnostic use and not Food and Drug Administration (FDA) cleared for this use.
###
PRESS CONTACT:
Verséa Health, Inc.
James M. Olin, CCO
1-800-397-0670
